RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

TYPE OF INFORMATION SEARCH RESULT

2021.09.17 | 15:09 | Permanent Information Releases / General Company News

Biogen Idec Inc

puce CHMP Recommends VUMERITY® (diroximel fumarate) for Approval in the European Union as a Treatment for Relapsing-Remitting Multiple Sclerosis - HTML (w)

2021.09.17 | 15:02 | Permanent Information Releases / Sales and Revenues

ST Dupont

puce S.T. Dupont : Résultats consolidés au 31 mars 2021 - HTML (w)

2021.09.17 | 14:26 | Share History / Voting Rights and Number of Shares

ELIS

puce Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 08 2021 - HTML (w)

2021.09.17 | 14:26 | Share History / Voting Rights and Number of Shares

ELIS

puce Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 08 2021 - HTML (w)

2021.09.17 | 13:45 | Permanent Information Releases / General Company News

Innate Pharma

puce Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021 - HTML (w)

2021.09.17 | 13:45 | Permanent Information Releases / General Company News

Innate Pharma

puce Monalizumab Data From COAST Trial Presented at ESMO Congress 2021 - HTML (w)

2021.09.17 | 13:30 | Permanent Information Releases / General Company News

NOVARTIS

puce Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS) - HTML (w)

2021.09.17 | 13:20 | Permanent Information Releases / General Company News

YARA

puce Share purchase by Yara Board member - HTML (w)

2021.09.17 | 13:15 | Permanent Information Releases / General Company News

GALAPAGOS

puce GALAPAGOS KONDIGT POSITIEVE CHMP OPINIE AAN VOOR JYSELECA® (FILGOTINIB) VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE ACTIEVE COLITIS ULCEROSA - HTML (w)

2021.09.17 | 13:15 | Permanent Information Releases / General Company News

GALAPAGOS

puce GALAPAGOS KONDIGT POSITIEVE CHMP OPINIE AAN VOOR JYSELECA® (FILGOTINIB) VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE ACTIEVE COLITIS ULCEROSA - HTML (w)

2021.09.17 | 13:15 | Permanent Information Releases / General Company News

GALAPAGOS

puce GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS - HTML (w)

2021.09.17 | 13:15 | Permanent Information Releases / General Company News

GALAPAGOS

puce GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS - HTML (w)

2021.09.17 | 13:10 | Permanent Information Releases / General Company News

ROCHE

puce Roche receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer - HTML (w)

2021.09.17 | 09:33 | Permanent Information Releases / General Company News

Esso

puce Rapport financier premier semestre 2021 - HTML (w)

2021.09.17 | 09:14 | Permanent Information Releases / General Company News

INVESTEC

puce Form 8.5 (EPT/RI) - Good Energy Group plc - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1000